In this study, we found that the downregulation of ST3GAL6 predicts a poor prognosis in LUAD samples, reinforcing the notion that ST3GAL6 may play an oncogenic or tumor-suppressive role which is dependent on the cancer type. This evidence concerns the gene ST3GAL6 and cancer.